[{"address1": "Kungsbroplan 3", "city": "Stockholm", "zip": "112 27", "country": "Sweden", "phone": "46 8 55 52 93 00", "website": "https://www.biogaia.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was founded in 1990 and is based in Stockholm, Sweden.", "fullTimeEmployees": 220, "companyOfficers": [{"maxAge": 1, "name": "Mr. Peter  Rothschild M.Sc. Econ., MBA", "age": 73, "title": "Founder & Chairman", "yearBorn": 1950, "fiscalYear": 2023, "totalPay": 1330000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Theresa P. Agnew", "age": 57, "title": "CEO & President", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 6750250, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alexander  Kotsinas M.Sc. (Eng.).", "age": 56, "title": "Executive VP & CFO", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 3067000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ludvig  Milesson", "age": 46, "title": "Chief Operating Officer", "yearBorn": 1977, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gianfranco  Grompone", "age": 48, "title": "Chief Scientific Officer and VP of Research & Development", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Caroline  Mofors", "age": 51, "title": "Chief Legal Officer", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Linda  Hagglund", "age": 50, "title": "Vice President of Marketing", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Angelika  Kjelldorff", "age": 54, "title": "Chief HR Officer", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Sebastian  Heimfors", "age": 49, "title": "VP & Chief Commercial Officer", "yearBorn": 1974, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Jonathan  Gromark", "title": "Sustainability Manager", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 8, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "open": 12.31, "dayLow": 12.31, "dayHigh": 12.31, "regularMarketOpen": 12.31, "regularMarketDayLow": 12.31, "regularMarketDayHigh": 12.31, "dividendRate": 0.18, "dividendYield": 0.015, "exDividendDate": 1715126400, "payoutRatio": 0.4774, "beta": 0.545, "trailingPE": 25.538462, "volume": 257, "regularMarketVolume": 257, "averageVolume": 4, "bid": 11.37, "ask": 11.82, "askSize": 43500, "marketCap": 970641856, "fiftyTwoWeekLow": 8.42, "fiftyTwoWeekHigh": 12.31, "priceToSalesTrailing12Months": 0.7088154, "fiftyDayAverage": 11.75, "twoHundredDayAverage": 10.7655, "trailingAnnualDividendRate": 1.9, "trailingAnnualDividendYield": "Infinity", "currency": "USD", "enterpriseValue": 178802144, "profitMargins": 0.29336, "floatShares": 80794936, "sharesOutstanding": 97454000, "heldPercentInsiders": 0.05406, "heldPercentInstitutions": 0.45598, "impliedSharesOutstanding": 101599000, "bookValue": 15.6, "priceToBook": 0.63846153, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "earningsQuarterlyGrowth": 0.378, "netIncomeToCommon": 401716992, "trailingEps": 0.39, "lastSplitFactor": "5:1", "lastSplitDate": 1652832000, "enterpriseToRevenue": 0.131, "enterpriseToEbitda": 0.362, "52WeekChange": 0.25266528, "SandP52WeekChange": 0.24014747, "lastDividendValue": 1.9, "lastDividendDate": 1715126400, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "BGLAF", "underlyingSymbol": "BGLAF", "shortName": "BIOGAIA AG", "longName": "BioGaia AB (publ)", "firstTradeDateEpochUtc": 1369834200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "819f764c-13c7-3e93-a865-bc6aba202a85", "messageBoardId": "finmb_3733605", "gmtOffSetMilliseconds": -14400000, "currentPrice": 9.96, "recommendationKey": "none", "totalCash": 1007742016, "totalCashPerShare": 9.979, "ebitda": 493828992, "quickRatio": 4.581, "currentRatio": 6.489, "totalRevenue": 1369385984, "revenuePerShare": 13.561, "returnOnAssets": 0.14798, "returnOnEquity": 0.23226999, "freeCashflow": 211844256, "operatingCashflow": 394032000, "earningsGrowth": 0.378, "revenueGrowth": 0.219, "grossMargins": 0.73837, "ebitdaMargins": 0.36062, "operatingMargins": 0.36755002, "financialCurrency": "SEK", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]